Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Significances of Bioengineering & Biosciences

Artificial Intelligence in Multimodal Retinal Imaging: A Systematic Review of Diagnostic Applications in Ocular and Systemic Diseases

Ameh Benson Agi1, Micheal Abimbola Oladosu2*, Moses Adondua Abah3, Dominic Agida Ochuele3, Abimbola Mary Oluwajembola2, Olaide Ayokunmi Oladosu4, Bukola Oluwaseyi Olufosoye5 and Olamide Yosola Falana6

1Department of Chemistry, College of Science, University of Siegen, Germany

2Department of Chemical Sciences, Faculty of Science, Anchor University, Nigeria

3Department of Biochemistry, Faculty of Pure and Applied Sciences, Federal University of Wukari, Nigeria

4Department of Computer Science, Faculty of Science and Technology, Babcock University, Nigeria

5Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Ambrose Alli University, Nigeria

6Department of Public Health, Teesside University, UK

*Corresponding author:Micheal Abimbola Oladosu, Department of Chemical Sciences, Faculty of Science, Anchor University, Ayobo, Ipaja, Lagos, Nigeria

Submission: November 19, 2025;Published: March 11, 2026

DOI: 10.31031/SBB.2026.07.000679

ISSN 2637-8078
Volume7 Issue 5

Abstract

Progress in Artificial Intelligence (AI) has transformed medical imaging, with retinal imaging becoming a crucial diagnostic tool for ocular and systemic illnesses. This systematic review examines the incorporation of AI in multimodal retinal imaging, which includes fundus photography, Optical Coherence Tomography (OCT), OCT angiography, and fluorescein angiography, along with its diagnostic applications for conditions such as diabetic retinopathy, age-related macular degeneration, glaucoma, and systemic diseases like cardiovascular and neurodegenerative disorders. A thorough examination of contemporary AI models reveals elevated sensitivity and specificity, frequently matching or surpassing that of experienced ophthalmologists. The paper emphasises AI’s ability to automate illness detection, improve early diagnosis, and facilitate scalable screening in resource-constrained environments. Nevertheless, obstacles persist, such as restricted dataset heterogeneity, absence of multicentre validation, and complications with clinical integration and algorithm transparency. Future investigations should prioritise the creation of different datasets, the standardisation of validation methodologies, and the development of interpretable AI systems that integrate effortlessly into clinical processes. AI-enhanced multimodal retinal imaging offers substantial potential for revolutionising precision diagnoses in ophthalmology and systemic medicine..

Keywords:Artificial intelligence; Multimodal retinal imaging; Diabetic retinopathy; Systemic diseases; Deep learning

Get access to the full text of this article